Basf (ETR:BAS) has been assigned a €60.00 ($69.77) price objective by UBS Group in a research report issued on Monday, February 4th, www.boersen-zeitung.de reports. The brokerage currently has a “neutral” rating on the basic materials company’s stock. UBS Group’s price objective would suggest a potential downside of 11.84% from the company’s current price.
A number of other research analysts have also recently issued reports on the company. Cfra set a €73.00 ($84.88) price objective on Basf and gave the company a “neutral” rating in a research note on Monday, October 29th. Barclays set a €92.00 ($106.98) target price on shares of Basf and gave the company a “buy” rating in a report on Friday, November 2nd. Independent Research set a €72.00 ($83.72) price target on shares of Basf and gave the stock a “neutral” rating in a research report on Wednesday, November 21st. Sanford C. Bernstein set a €84.00 ($97.67) price objective on shares of Basf and gave the stock a “neutral” rating in a research note on Monday, December 10th. Finally, Nord/LB set a €71.00 ($82.56) price objective on shares of Basf and gave the stock a “buy” rating in a report on Monday, December 10th. Ten investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of €76.62 ($89.09).
Shares of BAS traded up €1.07 ($1.24) during mid-day trading on Monday, reaching €68.06 ($79.14). 3,259,009 shares of the stock traded hands, compared to its average volume of 2,920,000. Basf has a 12-month low of €78.97 ($91.83) and a 12-month high of €98.70 ($114.77).
Basf Company Profile
BASF SE operates as a chemical company worldwide. It operates through five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions, and Oil & Gas. The Chemicals segment offers solvents, plasticizers, monomers, and glues, as well as raw materials for detergents, plastics, textile fibers, paints and coatings, crop protection products, and medicines.
Featured Story: What is the NASDAQ Stock Market?
Receive News & Ratings for Basf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf and related companies with MarketBeat.com's FREE daily email newsletter.